Stock listing

KRX:095700 Genexine, Inc. (제넥신) 주가

Follow Genexine, Inc. into a list and get an email when it puts out news.

Share price · KRX:095700

₩1,776.00 KRW -30.00 (-1.7%)

Close on Nov 20, 2026

Past year -64.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩1,758.00 – ₩1,875.00 KRWNov 20, 2026
Volume
77,703 sharesNov 20, 2026
Market cap
₩80.77B KRWAt the close on Nov 20, 2026 · price × 45.48M shares outstanding
52-week range
₩1,758.00 – ₩7,490.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩1.21B KRWMedian day 119,063 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Genexine, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:095700 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩1,776.00-30.00-1.7%₩1,875.00₩1,875.00₩1,758.0077,703
₩1,806.00-80.00-4.2%₩1,886.00₩1,924.00₩1,805.00114,046
₩1,886.00-9.00-0.5%₩1,893.00₩1,924.00₩1,830.0053,217
₩1,895.00-68.00-3.5%₩2,015.00₩2,020.00₩1,881.00128,781
₩1,963.00-77.00-3.8%₩2,040.00₩2,060.00₩1,961.00169,504
₩2,040.00-30.00-1.4%₩2,070.00₩2,085.00₩2,000.0058,309
₩2,070.00+55.00+2.7%₩2,050.00₩2,080.00₩2,000.0085,866
₩2,015.00+27.00+1.4%₩2,040.00₩2,060.00₩1,995.0088,509
₩1,988.00-52.00-2.5%₩2,000.00₩2,090.00₩1,988.0087,323
₩2,040.00-30.00-1.4%₩2,055.00₩2,070.00₩1,983.0096,525
₩2,070.00+15.00+0.7%₩2,090.00₩2,105.00₩1,992.0085,603
₩2,055.00-5.00-0.2%₩2,100.00₩2,100.00₩1,991.00143,301
₩2,060.00-80.00-3.7%₩2,145.00₩2,175.00₩2,030.00101,290
₩2,140.00-20.00-0.9%₩2,105.00₩2,185.00₩2,105.0092,912
₩2,160.00-5.00-0.2%₩2,215.00₩2,215.00₩2,130.00145,820
₩2,165.00-85.00-3.8%₩2,265.00₩2,265.00₩2,165.0082,317
₩2,250.00-75.00-3.2%₩2,325.00₩2,355.00₩2,220.00189,004
₩2,325.00-60.00-2.5%₩2,355.00₩2,425.00₩2,300.00113,459
₩2,385.00-55.00-2.3%₩2,440.00₩2,440.00₩2,320.0069,361
₩2,440.00-20.00-0.8%₩2,455.00₩2,455.00₩2,350.0097,974
₩2,460.00-80.00-3.1%₩2,585.00₩2,585.00₩2,460.00105,879
₩2,540.00-60.00-2.3%₩2,670.00₩2,670.00₩2,535.0098,260
₩2,600.00-25.00-1.0%₩2,600.00₩2,660.00₩2,555.0071,941
₩2,625.00-20.00-0.8%₩2,695.00₩2,695.00₩2,515.0074,066
₩2,645.00+65.00+2.5%₩2,580.00₩2,685.00₩2,580.0079,051
₩2,580.00-110.00-4.1%₩2,585.00₩2,675.00₩2,510.00186,558
₩2,690.00-50.00-1.8%₩2,760.00₩2,820.00₩2,665.00118,273
₩2,740.00-35.00-1.3%₩2,740.00₩2,800.00₩2,640.00144,732
₩2,775.00-130.00-4.5%₩2,980.00₩2,980.00₩2,770.00141,400
₩2,905.00-110.00-3.6%₩3,005.00₩3,015.00₩2,900.00182,019
₩3,015.00+180.00+6.3%₩2,985.00₩3,625.00₩2,980.002,089,786
₩2,835.00+65.00+2.3%₩2,815.00₩2,850.00₩2,760.0076,301
₩2,770.00-35.00-1.2%₩2,805.00₩2,875.00₩2,750.0085,263
₩2,805.00+85.00+3.1%₩2,700.00₩2,810.00₩2,700.00121,310
₩2,720.00+45.00+1.7%₩2,710.00₩2,775.00₩2,675.0064,329
₩2,675.00-95.00-3.4%₩2,770.00₩2,770.00₩2,640.00105,428
₩2,770.00+35.00+1.3%₩2,740.00₩2,845.00₩2,740.00195,805
₩2,735.00+10.00+0.4%₩2,730.00₩2,775.00₩2,700.00113,839
₩2,725.00-265.00-8.9%₩2,975.00₩2,990.00₩2,680.00439,623
₩2,990.00+90.00+3.1%₩2,895.00₩3,045.00₩2,800.00223,674
₩2,900.00+65.00+2.3%₩2,920.00₩2,920.00₩2,775.00192,278
₩2,835.00+40.00+1.4%₩2,800.00₩2,870.00₩2,775.0066,861
₩2,795.00-10.00-0.4%₩2,800.00₩2,810.00₩2,720.0089,293
₩2,805.00+15.00+0.5%₩2,865.00₩2,905.00₩2,800.0091,163
₩2,790.00-45.00-1.6%₩2,835.00₩2,895.00₩2,720.00112,257
₩2,835.00-55.00-1.9%₩2,900.00₩2,900.00₩2,815.00101,847
₩2,890.00-70.00-2.4%₩2,980.00₩2,980.00₩2,860.00163,964
₩2,960.000.000.0%₩3,020.00₩3,020.00₩2,870.00119,853
₩2,960.00-95.00-3.1%₩3,055.00₩3,055.00₩2,905.00353,349
₩3,055.00+35.00+1.2%₩3,020.00₩3,155.00₩2,960.00301,263
₩3,020.00-240.00-7.4%₩3,290.00₩3,320.00₩3,005.00622,684
₩3,260.00+445.00+15.8%₩2,845.00₩3,630.00₩2,735.003,331,659
₩2,815.00-195.00-6.5%₩3,030.00₩3,030.00₩2,812.00351,736
₩3,010.00+365.00+13.8%₩2,735.00₩3,260.00₩2,640.001,341,470
₩2,645.00-90.00-3.3%₩2,740.00₩2,740.00₩2,545.00221,151
₩2,735.00-20.00-0.7%₩2,760.00₩2,800.00₩2,720.00164,089
₩2,755.00-195.00-6.6%₩2,910.00₩2,920.00₩2,730.00401,198
₩2,950.00+100.00+3.5%₩2,920.00₩3,025.00₩2,840.00322,078
₩2,850.00-300.00-9.5%₩3,150.00₩3,160.00₩2,735.00561,520
₩3,150.00-175.00-5.3%₩3,325.00₩3,555.00₩3,070.00918,612
₩3,325.00+325.00+10.8%₩3,055.00₩3,880.00₩2,870.005,293,631
₩3,000.00+520.00+21.0%₩3,100.00₩3,220.00₩2,795.003,250,742

Splits

3 splits since 2016 · KRX:095700 · every price before a split is adjusted for it

DayRatioWhat
13-for-10Split
106-for-99Split
2-for-1Split
Ticker
KRX:095700
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

What changed lately

Latest news

All Genexine, Inc. news

Genexine, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in the last 12 months · 1 in all · newest Sep 15, 2026 · oldest 2026
Decks
1 deck · latest January 2023

Valuation

EV/sales 12.0× against a median of 4.9×: 6th lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩59.51B KRW
P/E
Loss
EV/sales
12.0×
EV/EBITDA
Negative EBITDA
Price/book
0.4×
Gross margin
−24.9%
Operating margin
−798.0%
Net margin
−650.0%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Genexine, Inc. · KRX:095700US$60.01MUS$44.21Mn/a12.0×n/a0.4×−650.0%0.0×n/a
Neumora Therapeutics, Inc. · NASDAQ:NMRAUS$63.01MUS$30.65Mn/a1,916×n/a3.4×n/a2.9×1.07
Poolbeg Pharma PLC · LSE:POLBUS$61.42MUS$55.12Mn/an/an/a7.0×n/a0.0×n/a
vTv Therapeutics Inc. · NASDAQ:VTVTUS$61.33M−US$15.84Mn/a−0.4×n/a0.9×−20.8%0.0×1.28
Oncopeptides AB · OMXSTO:ONCOUS$61.25MUS$59.05Mn/a6.3×n/a25.1×−223.6%5.4×n/a
ViGenCell, Inc. · KRX:308080US$61.07MUS$44.61Mn/a65.1×n/a2.1×n/a0.2×n/a
HemoGenyx Pharmaceuticals PLC · LSE:HEMOUS$60.45MUS$56.88Mn/an/an/a10.7×n/a0.4×n/a
GlycoNex, Inc. · TPEX:4168US$59.91MUS$57.19Mn/a84.9×n/a2.3×n/a0.6×n/a
ISU Abxis Co., Ltd. · KRX:086890US$59.84MUS$42.28Mn/a1.1×n/a0.7×−16.0%0.0×n/a
Rani Therapeutics Holdings, Inc. · NASDAQ:RANIUS$58.99MUS$16.85Mn/a2.6×n/a1.7×−493.0%0.1×2.21
HeXun Biosciences Co Ltd · TPEX:6986US$57.19MUS$32.04M16.2×3.4×6.5×1.8×37.7%0.0×n/a
Median of the othersUS$60.76MUS$43.45M16.2×4.9×6.5×2.2×−20.8%0.1×1.28

Team and board

OfficerRole
Jaehyun ChoiExecutive, CEO
Sungjune HongExecutive, CEO
Jongsoo LeeInvestor Relations

Events

QuarterResultsShare move
Q2 2026Aug 18, 2026−5.3%
Q1 2026May 18, 2026−10.9%
Q4 2025Mar 18, 2026−5.0%
Q3 2025Nov 14, 2025−5.1%
Q2 2025Aug 29, 2025−7.7%
Q1 2025May 12, 2025 · After close+1.6%
Q4 2024Mar 13, 2025−0.8%
Q3 2024Nov 12, 2024 · After close−4.3%
Q2 2024Aug 13, 2024 · After close+2.5%
Q1 2024May 14, 2024 · After close+0.6%
All 20 quarters
QuarterResultsShare move
Q4 2023Mar 28, 2024 · Before open−2.5%
Q3 2023Nov 14, 2023 · After close+1.9%
Q2 2023Aug 14, 2023 · After close+0.6%
Q1 2023May 15, 2023 · After close−2.7%
Q4 2022Feb 10, 2023 · After close−1.5%
Q3 2022Nov 14, 2022 · After close+7.0%
Q2 2022Aug 16, 2022 · After close−4.8%
Q1 2022May 16, 2022 · After close+0.3%
Q4 2021Mar 17, 2022 · After close+1.7%
Q3 2021Nov 15, 2021 · After close−0.6%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (January 2023)Investor deck30 slidesJanuary 2023

Open Decks

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue4.57B2.93B4.43B16.1B36.8B18.5B11.3B12.9B28.5B11.4B
Cost of revenue4.96B4.17B4.04B4.78B5.02B6.87B3.85B6.33B10.7B4.78B
Gross profit-385.7M-1.24B387.5M11.4B31.8B11.7B7.45B6.55B17.8B6.57B
Research and development26.6B22.0B26.3B26.4B33.1B39.2B
Selling, general and administrative3.85B12.5B13.7B17.0B16.5B10.6B10.7B11.2B8.98B16.5B
Operating income-36.1B-36.9B-42.4B-34.5B-20.2B-46.6B-44.5B-38.2B-26.9B-30.9B
Depreciation and amortization7.03B4.37B4.63B4.87B3.30B2.92B2.50B1.65B2.03B2.21B
EBITDA-29.0B-32.6B-37.8B-29.6B-16.9B-43.7B-42.0B-36.5B-24.9B-28.7B
Interest expense2.44B2.65B4.11B3.31B492.4M2.92B0000
Income before tax-27.2B-65.4B-66.9B-57.1B-48.6B27.5B-16.5B-34.1B-19.3B-30.9B
Net income-27.2B-63.7B-66.9B-56.3B-47.7B27.6B-16.5B-34.1B-19.3B-30.9B
Earnings per share, basic-598.40-1,400.75-1,613.36-1,721.54-1,382.801,116.28-694.79-1,209.39-698.54-1,260.91

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents9.15B1.16B6.03B17.9B27.8B5.21B19.1B57.0B11.8B24.5B
Short-term investments25.8B30.9B58.5B4.00B01.50B63.5B115.3B36.9B
Receivables300.3M4.78B10.7B9.38B1.03B2.74B3.96B2.49B14.7B5.60B
Inventory3.12B3.81B12.0B7.17B128.6M
Current assets45.9B46.9B92.2B52.4B43.8B20.6B95.8B177.5B28.9B71.9B
Property, plant and equipment118.9B114.2B110.9B112.0B71.9B49.8B47.2B41.3B23.6B
Total assets371.3B345.0B376.6B388.8B636.9B596.9B358.2B374.8B140.7B198.7B
Current liabilities116.9B54.0B54.5B78.9B59.2B40.2B22.6B10.8B13.0B26.1B
Long-term debt6.56B27.1B22.7B18.5B40.6B15.8B28.9B34.6B11.5B0
Total debt26.0B29.2B34.6B14.5B
Total liabilities124.5B83.4B79.7B112.6B119.1B61.3B61.3B54.3B26.8B28.5B
Shareholders' equity246.8B261.7B296.6B276.2B517.7B535.6B296.9B320.5B113.9B170.2B
Shares outstanding45.5M45.5M41.4M32.7M34.5M24.7M23.8M28.2M27.7M24.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-29.6B-1.65B-38.1B-39.8B-12.7B-22.7B-41.6B-20.1B-26.1B-14.1B
Capital spending-14.8B-7.30B-7.38B-31.7B-56.4B-22.2B-3.96B-8.01B-20.5B-5.07B
Free cash flow-44.3B-8.95B-45.4B-71.6B-69.8B-46.8B-45.5B-28.1B-46.6B-19.2B
Cash from investing-11.2B-34.3B-1.92B-7.70B-64.4B1.64B-185.6B17.8B-53.6B
Cash from financing7.96B60.4B31.6B43.1B73.4B3.33B250.9B-3.64B81.1B
Share buybacks84.2B1.98B13.4B61.9B3.50B206.2B4.06B61.4B
Change in cash7.99B-4.87B-11.9B-9.85B22.6B-13.9B-36.6B45.2B-12.0B13.4B

Open Financials

Cap table

Built by 6ix from Genexine, Inc.’s releases

Common shares
45,479,667
Fully diluted
45,479,667

Fully diluted

LineShares
Common shares45,479,667

Share count over time

CountShares
Nov 22, 202645,479,667

Open Cap table

Shareholders

HolderSharesValueAs of
Vanguard Total International Stock Index Fund576KUS$994KJul 31, 2026
Vanguard Developed Markets Index Fund376KUS$614KJun 30, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund191KUS$329KJul 31, 2026
Emerging Markets Core Equity 2 Portfolio180KUS$311KJul 31, 2026
Vanguard Pacific Stock Index Fund39,179US$67,590Jul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF26,020US$42,407Jun 30, 2026
State Street(R) SPDR(R) S&P(R) International Small Cap ETF21,130US$34,437Jun 30, 2026
The Emerging Markets Small Cap Series12,672US$21,860Jul 31, 2026
Vanguard Total World Stock Index Fund12,258US$21,147Jul 31, 2026
World ex U.S. Core Equity Portfolio9,961US$17,183Jul 31, 2026
All 15 holders
HolderSharesValueAs of
Vanguard ESG International Stock ETF6,305US$15,325May 31, 2026
Avantis Emerging Markets Equity ETF1,908US$4,638May 31, 2026
Avantis Emerging Markets Small Cap Equity ETF256US$622May 31, 2026
Avantis Responsible Emerging Markets Equity ETF113US$275May 31, 2026
Avantis Emerging Markets Equity Fund105US$255May 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jaehyun ChoiExecutive, CEO · Since at least Sep 15, 2026
Jongsoo LeeInvestor Relations · Since at least Sep 15, 2026
Sungjune HongExecutive, CEO · Since at least Nov 6, 2026

Open People

Log in to ask 6ix AI your own questions about Genexine, Inc.